Bo Huang

33PUBLICATIONS
76CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Sep 08, 2026
In vivo genome-wide CRISPR screens identify FOXR1 as a suppressor of CD8+ T cell antitumor immunity.

|Jul 13, 2026
Divergent Tumor Immune Microenvironment and Response to Neoadjuvant Chemoimmunotherapy in Resectable Non-Small Cell Lung Cancer: A Single-Arm Phase II Trial.

|Apr 02, 2026
Revitalizing p-GSK-3β via cysteine sulfenylation promotes hepatic insulin resistance by differentially regulating glycogenesis and gluconeogenesis.

Jie Chen, Zhuohang Liu, Jian Gu

|Mar 14, 2026
IDO1 regulating ROS rhythm reveals glycogenolysis/PPP as a cancer treatment target.

Nannan Zhou, Zheng Ling, Xiankai Cao

|Jan 30, 2026
Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA-LNP.

Yabo Zhou, Dianheng Wang, Shujing Wang

|Nov 19, 2025
AhR-Siglec-15 axis regulates lysosomal Ca2+ release for sonic hedgehog medulloblastoma growth via TRPML1.

Zhenfeng Wang, Shunshun Li, Xu Sun

Pageof 6

Frequent Collaborators

14 joint publications

Yabo Zhou

6 joint publications

Yi Zhang

6 joint publications

Jiadi Lv

6 joint publications

Li Zhou